Butterfly Network Inc. Class A Common Stock (BFLY) Stock Price Today
Leonardo DRS wins 10-year NASA SEWP VI contract to supply federal agencies with defense tech through 2036
Leonardo DRS secured a 10-year prime contract under NASA's SEWP VI program, enabling federal agencies to quickly procure its defense products and services until 2036. This contract extends DRS's role as a SEWP prime contractor, supporting key militar...
Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.
Honey Badger Silver announced promising assay results from its first exploration program at the Yava Project in Nunavut, revealing high-grade silver, copper, gold, zinc, and lead samples. This marks the first systematic work at Yava in nearly two dec...
Brasil DNA Virtual Roadshow connects 187 travel pros with 90+ Brazilian suppliers, boosting tourism ties.
The Brasil DNA Virtual Roadshow held in October 2026 brought together 187 travel professionals from the US and Canada, facilitating 551 connections with over 90 Brazilian tourism suppliers across 54 booths. The event generated 741 leads and featured ...
Remittix sets Nov 24 launch for RTX token as Ethereum staking expands and Cardano hits transaction record
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
Global microbiology testing market set to grow at 9% CAGR, reaching $13.7B by 2034 driven by infectious disease demand.
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
Enliven appoints Kristine Ball to board as it prepares Phase 3 trial of relcobatinib for leukemia.
Enliven Therapeutics has appointed Kristine Ball to its Board of Directors to leverage her extensive biopharmaceutical leadership experience as the company prepares to start a pivotal Phase 3 trial of relcobatinib for chronic myeloid leukemia by the ...
Coherus Oncology to release interim clinical data on tagmokitug for solid tumors on Oct 28, 2026
Coherus Oncology announced it will disclose interim clinical data for tagmokitug, a cytolytic CCR8 antibody combined with toripalimab, targeting multiple solid tumors. The data release is scheduled for October 28, 2026, with a webcast hosted by compa...
Touchmark Bancshares' Chief Lending Officer Addam Taussig departs; CEO Bobby Krimmel takes over lending duties.
Touchmark Bancshares announced that Addam Taussig, Executive Vice President and Chief Lending Officer, has left the company. Bobby Krimmel, the President and CEO, will immediately assume the Chief Lending Officer responsibilities. The bank emphasizes...
PicPay to showcase Brazil's AI and banking innovations at Money 20/20 USA 2026 in Las Vegas
PicPay, one of Brazil's largest digital banks, will participate in Money 20/20 USA 2026 in Las Vegas on October 19. CEO Eduardo Chedid and other senior leaders will lead sessions discussing Brazil's advances in connected banking, Pix, Open Finance, a...
Aktis Oncology undervalued despite strong cash and promising drug programs, with key data expected in 2027
Aktis Oncology is trading below its IPO price despite holding $517.3 million in cash and a $1.2 billion partnership with Eli Lilly, giving it financial stability through 2029. The company is developing two innovative radiopharmaceutical drugs, AKY-11...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.